[go: up one dir, main page]

CN116392647B - Silk fibroin-based three-dimensional structure bilayer membrane for periodontal regeneration and preparation method and application thereof - Google Patents

Silk fibroin-based three-dimensional structure bilayer membrane for periodontal regeneration and preparation method and application thereof Download PDF

Info

Publication number
CN116392647B
CN116392647B CN202310557229.4A CN202310557229A CN116392647B CN 116392647 B CN116392647 B CN 116392647B CN 202310557229 A CN202310557229 A CN 202310557229A CN 116392647 B CN116392647 B CN 116392647B
Authority
CN
China
Prior art keywords
layer
preparation
membrane
silk fibroin
silk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202310557229.4A
Other languages
Chinese (zh)
Other versions
CN116392647A (en
Inventor
王驰巍
仇可新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Liyuan Medical Technology Co ltd
Original Assignee
Shanghai Liyuan Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Liyuan Medical Technology Co ltd filed Critical Shanghai Liyuan Medical Technology Co ltd
Priority to CN202310557229.4A priority Critical patent/CN116392647B/en
Publication of CN116392647A publication Critical patent/CN116392647A/en
Application granted granted Critical
Publication of CN116392647B publication Critical patent/CN116392647B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/028Other inorganic materials not covered by A61L31/022 - A61L31/026
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/047Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146Porous materials, e.g. foams or sponges
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0015Electro-spinning characterised by the initial state of the material
    • D01D5/003Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D01D5/0038Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0061Electro-spinning characterised by the electro-spinning apparatus
    • D01D5/0076Electro-spinning characterised by the electro-spinning apparatus characterised by the collecting device, e.g. drum, wheel, endless belt, plate or grid
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0061Electro-spinning characterised by the electro-spinning apparatus
    • D01D5/0092Electro-spinning characterised by the electro-spinning apparatus characterised by the electrical field, e.g. combined with a magnetic fields, using biased or alternating fields
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02WCLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W90/00Enabling technologies or technologies with a potential or indirect contribution to greenhouse gas [GHG] emissions mitigation
    • Y02W90/10Bio-packaging, e.g. packing containers made from renewable resources or bio-plastics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Textile Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明提供一种用于牙周再生的丝素基三维结构双层膜及其制备方法和应用,所述用于牙周再生的丝素基三维结构双层膜包括内层的多孔疏松层和外层的致密层,所述多孔疏松层是丝素蛋白和纳米羟基磷灰石组成的纳米纤维膜,所述致密层是丝素蛋白与生物可降解材料组成的纳米纤维膜,所述多孔疏松层和致密层之间形成交联结构。本发明的丝素基三维结构双层膜具有三维结构,具有良好的机械屏障作用,可以诱导骨组织再生作用,膜结构柔软,与牙周组织贴合良好,具有较好的力学性能和降解性能,制备方法操作简单,实验制备条件温和的优点,适于大规模批量生产。

The present invention provides a silk-based three-dimensional structure double-layer membrane for periodontal regeneration, and a preparation method and application thereof, wherein the silk-based three-dimensional structure double-layer membrane for periodontal regeneration comprises an inner porous loose layer and an outer dense layer, wherein the porous loose layer is a nanofiber membrane composed of silk fibroin and nano-hydroxyapatite, and the dense layer is a nanofiber membrane composed of silk fibroin and biodegradable materials, and a cross-linked structure is formed between the porous loose layer and the dense layer. The silk-based three-dimensional structure double-layer membrane of the present invention has a three-dimensional structure, has a good mechanical barrier effect, can induce bone tissue regeneration, has a soft membrane structure, is well attached to periodontal tissue, has good mechanical properties and degradation properties, has the advantages of simple preparation method operation and mild experimental preparation conditions, and is suitable for large-scale batch production.

Description

一种用于牙周再生的丝素基三维结构双层膜及其制备方法和 应用A silk-based three-dimensional double-layer membrane for periodontal regeneration and its preparation method and application

技术领域Technical Field

本发明属于纳米纤维双层膜的制备领域,涉及一种用于牙周再生的丝素基三维结构双层膜及其制备方法和应用。The invention belongs to the field of preparation of nanofiber double-layer membranes, and relates to a silk-based three-dimensional structure double-layer membrane for periodontal regeneration, and a preparation method and application thereof.

背景技术Background technique

口腔种植是指利用生物材料制作人工牙根、牙冠等,以修复缺失的牙齿和周围组织,实现长期稳定、舒适的咀嚼功能和牙齿外形。然而,由于牙齿缺失后,牙槽骨常因失去功能性刺激等因素而逐渐萎缩,导致种植修复中常见的骨量不足问题,成为该领域面临的主要挑战之一。因此,在进行口腔种植手术前,需要对患者的骨质进行评估。对于患者牙槽骨骨量较少的情况,需要先进行植骨手术,利用骨粉、骨膜等科技再生材料代替人骨,这种技术被称为引导骨组织再生术(Guided bone regeneration,GBR)。在整个种植修复流程中,部分患者需要进行骨增量手术,而其中一部分需要用到骨粉和口腔修复膜。采用口腔修复膜材料在牙种植中可以促进骨再生,提高植体稳定性,同时保证骨和植骨发育良好,具有良好的治疗效果,对于改善患者口腔健康、提升生活质量具有重要价值。Oral implant refers to the use of biomaterials to make artificial roots, crowns, etc. to repair missing teeth and surrounding tissues, and achieve long-term stable and comfortable chewing function and tooth appearance. However, after tooth loss, the alveolar bone often gradually shrinks due to factors such as loss of functional stimulation, resulting in the common problem of insufficient bone mass in implant restoration, which has become one of the main challenges faced by this field. Therefore, before performing oral implant surgery, the patient's bone quality needs to be evaluated. For patients with less alveolar bone mass, bone grafting surgery is required first, using technological regenerative materials such as bone powder and periosteum to replace human bone. This technology is called guided bone regeneration (GBR). During the entire implant restoration process, some patients need bone augmentation surgery, and some of them need bone powder and oral repair membranes. The use of oral repair membrane materials in dental implants can promote bone regeneration, improve implant stability, and ensure good development of bone and grafted bone. It has good therapeutic effects and is of great value in improving patients' oral health and quality of life.

通过应用口腔修复膜对骨缺损部位进行覆盖,可以形成一层机械屏障,从而达到封闭效果。这种覆盖可以缓解覆盖组织的压力,同时对血凝块进行保护,形成良好的成骨空间。该屏障可以阻挡影响骨形成的纤维细胞和结缔组织等,使具有成长潜力的前体成骨细胞进入到骨缺损区,从而诱导骨缺损区的骨修复再生,增加口腔种植修复的成功率。By covering the bone defect with an oral repair membrane, a mechanical barrier can be formed to achieve a sealing effect. This covering can relieve the pressure of the covering tissue, protect the blood clot, and form a good bone formation space. The barrier can block fibroblasts and connective tissue that affect bone formation, allowing precursor osteoblasts with growth potential to enter the bone defect area, thereby inducing bone repair and regeneration in the bone defect area and increasing the success rate of oral implant restoration.

口腔修复膜种类繁多,传统的合金材料和高分子材料来源的口腔修复膜因其生物相容性差和不可降解等缺陷而逐渐被淘汰。胶原类口腔修复膜目前占据主要市场,但市场上已有的同类型产品或多或少存在一些缺陷:There are many types of oral repair membranes. Traditional oral repair membranes made of alloy materials and polymer materials are gradually being eliminated due to their poor biocompatibility and non-degradability. Collagen oral repair membranes currently occupy the main market, but similar products on the market have more or less some defects:

(1)胶原降解速度快,在修复后期无法维持空间结构;(1) Collagen degrades quickly and cannot maintain its spatial structure in the later stages of repair;

(2)致密面不能阻止软组织侵入骨缺损区,达不到屏障膜的预期效果;(2) The dense surface cannot prevent soft tissue from invading the bone defect area, and the expected effect of the barrier membrane cannot be achieved;

(3)疏松面吸渗性不佳,不能有效锁住渗血,诱导骨再生效果不佳;(3) The porous surface has poor permeability and cannot effectively lock in the blood seepage, resulting in poor induction of bone regeneration;

(4)口腔修复膜手感僵硬,贴附效果不佳,会影响手术操作的便利性。(4) The oral repair membrane feels stiff and has poor adhesion, which will affect the convenience of surgical operation.

相比之下,丝素蛋白(silk fibroin,SF)作为天然高分子材料,具有良好的生物降解性、机械强度和生物相容性,在骨、软骨、肝脏和皮肤的组织工程中得到广泛应用。然而,丝素蛋白的黏附性和亲水性较差,限制了其在医用材料方面的应用。经过交联改性后,丝素蛋白可以诱导形成β-折叠结构,从而提高材料的细胞粘附力和弹性模量。采用静电纺丝技术可以制备出纳米级的丝素蛋白纤维网,其力学强度较高,更接近于天然骨膜的物理结构。电纺单层膜存在厚度薄、强度差、易遇水溶胀等缺点。In contrast, silk fibroin (SF), as a natural polymer material, has good biodegradability, mechanical strength and biocompatibility, and is widely used in tissue engineering of bone, cartilage, liver and skin. However, the poor adhesion and hydrophilicity of silk fibroin limit its application in medical materials. After cross-linking modification, silk fibroin can induce the formation of β-folding structure, thereby improving the cell adhesion and elastic modulus of the material. Electrospinning technology can be used to prepare nano-scale silk fibroin fiber mesh, which has high mechanical strength and is closer to the physical structure of natural periosteum. Electrospun monolayer membranes have the disadvantages of thin thickness, poor strength, and easy swelling in water.

因此,在本领域中,期望开发一种能够具有理想的组织贴合性、力学性能和降解周期的材料。Therefore, in the art, it is desired to develop a material that can have ideal tissue conformability, mechanical properties and degradation cycle.

发明内容Summary of the invention

针对现有技术的不足,本发明的目的在于提供一种用于牙周再生的丝素基三维结构双层膜及其制备方法和应用。In view of the deficiencies of the prior art, the object of the present invention is to provide a silk-based three-dimensional structured double-layer membrane for periodontal regeneration, and a preparation method and application thereof.

为达到此发明目的,本发明采用以下技术方案:In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:

一方面,本发明提供一种用于牙周再生的丝素基三维结构双层膜,其包括内层的多孔疏松层和外层的致密层,所述多孔疏松层是丝素蛋白和纳米羟基磷灰石组成的纳米纤维膜,所述致密层是丝素蛋白与生物可降解材料组成的纳米纤维膜,所述多孔疏松层和致密层之间形成交联结构。On the one hand, the present invention provides a silk-based three-dimensional structure double-layer membrane for periodontal regeneration, which includes an inner porous loose layer and an outer dense layer, wherein the porous loose layer is a nanofiber membrane composed of silk fibroin and nano-hydroxyapatite, and the dense layer is a nanofiber membrane composed of silk fibroin and biodegradable materials, and a cross-linked structure is formed between the porous loose layer and the dense layer.

在本发明中,将丝素蛋白与纳米羟基磷灰石(nano-hydroxyapatite,nHA)复合,增加表面粗糙度并大幅提高机械强度。此外,添加高分子生物可降解材料可以进一步增加纳米纤维膜的稳定性和力学强度。多孔疏松层和外层的致密层形成交联结构,能够诱导丝素蛋白形成β-折叠结构,使得本发明的牙周再生的丝素基双层膜具有三维结构,相较于胶原膜具有更为理想的组织贴合性、力学性能、降解周期,在临床应用上具有较大的前景。In the present invention, silk fibroin is compounded with nano-hydroxyapatite (nHA) to increase the surface roughness and greatly improve the mechanical strength. In addition, the addition of polymer biodegradable materials can further increase the stability and mechanical strength of the nanofiber membrane. The porous loose layer and the outer dense layer form a cross-linked structure, which can induce silk fibroin to form a β-folded structure, so that the silk-based double-layer membrane for periodontal regeneration of the present invention has a three-dimensional structure, which has more ideal tissue adhesion, mechanical properties, and degradation cycle than collagen membranes, and has great prospects in clinical applications.

优选地,所述多孔疏松层中纳米羟基磷灰石的质量占比为10%~30%,例如10%、13%、15%、18%、20%、23%、25%、28%或30%。Preferably, the mass proportion of nano-hydroxyapatite in the porous loose layer is 10% to 30%, for example, 10%, 13%, 15%, 18%, 20%, 23%, 25%, 28% or 30%.

优选地,所述纳米羟基磷灰石的粒径为20~40nm,例如20nm、23nm、25nm、28nm、30nm、35nm、38nm或40nm。由于本发明所述用于牙周再生的丝素基三维结构双层膜是通过静电纺丝制备得到的,因此,纳米羟基磷灰石的粒径通过研磨、过筛维持在20~40nm,使其更好的分散在静电纺丝溶液中,避免沉降;同时在静电纺丝过程中不易堵针头,使纺丝过程更加顺畅。Preferably, the particle size of the nano-hydroxyapatite is 20-40 nm, for example, 20 nm, 23 nm, 25 nm, 28 nm, 30 nm, 35 nm, 38 nm or 40 nm. Since the silk-based three-dimensional structured double-layer membrane for periodontal regeneration of the present invention is prepared by electrospinning, the particle size of the nano-hydroxyapatite is maintained at 20-40 nm by grinding and sieving, so that it is better dispersed in the electrospinning solution to avoid sedimentation; at the same time, it is not easy to block the needle during the electrospinning process, making the spinning process smoother.

优选地,所述致密层中丝素蛋白的重量百分比为50%~100%,例如50%、55%、60%、65%、70%、75%、80%、85%、90%、95%或100%。Preferably, the weight percentage of silk fibroin in the dense layer is 50% to 100%, for example 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 100%.

优选地,所述生物可降解材料选自聚乳酸、聚己内酯或聚羟基丁酸戊酸共聚酯中的任意一种或至少两种的组合。Preferably, the biodegradable material is selected from any one of polylactic acid, polycaprolactone or polyhydroxybutyrate-valeric acid copolyester or a combination of at least two thereof.

优选地,所述交联使用的交联剂为碳化二亚胺盐(EDC)和羟基丁二酰亚胺(NHS)。Preferably, the crosslinking agent used in the crosslinking is dicarbodiimide salt (EDC) and hydroxysuccinimide (NHS).

优选地,所述碳化二亚胺盐和羟基丁二酰亚胺的质量比为20%~30%,例如20%、23%、25%、28%或30%。Preferably, the mass ratio of the carbodiimide salt to hydroxysuccinimide is 20% to 30%, for example, 20%, 23%, 25%, 28% or 30%.

在本发明中,在多孔疏松层和致密层进行交联的过程中,能够诱导丝素蛋白形成β-折叠结构,形成的丝素基超薄双层膜与牙周组织有更好的贴合性,相比而言,市售双层胶原膜手感僵硬、贴附效果不佳。In the present invention, during the cross-linking process of the porous loose layer and the dense layer, silk fibroin can be induced to form a β-folded structure, and the formed silk-based ultra-thin double-layer membrane has better adhesion to the periodontal tissue. In comparison, the commercially available double-layer collagen membrane feels stiff and has poor adhesion effect.

另一方面,本发明提供了如上所述的用于牙周再生的丝素基三维结构双层膜的制备方法,所述制备方法包括以下步骤:On the other hand, the present invention provides a method for preparing the silk-based three-dimensional structured double-layer membrane for periodontal regeneration as described above, the preparation method comprising the following steps:

(1)以含有丝素蛋白与纳米羟基磷灰石的溶液为静电纺丝液,通过静电纺丝得到多孔疏松层;(1) using a solution containing silk fibroin and nano-hydroxyapatite as an electrospinning solution, and obtaining a porous loose layer by electrospinning;

(2)以含有丝素蛋白与生物可降解材料的溶液为静电纺丝液,通过静电纺丝,在得到的多孔疏松层上接收并得到致密层;(2) using a solution containing silk fibroin and biodegradable materials as an electrospinning solution, and receiving and obtaining a dense layer on the obtained porous loose layer through electrospinning;

(3)使用交联剂使得多孔疏松层和致密层发生交联,得到所述用于牙周再生的丝素基三维结构双层膜。(3) Using a cross-linking agent to cross-link the porous loose layer and the dense layer to obtain the silk-based three-dimensional structure double-layer membrane for periodontal regeneration.

在本发明中,通过静电纺丝在多孔疏松层上形成丝素蛋白与生物可降解材料的致密层,而后通过发生交联,能够诱导丝素蛋白形成β-折叠结构,形成的丝素基超薄双层膜与牙周组织有更好的贴合性,相比而言,市售双层胶原膜手感僵硬、贴附效果不佳。In the present invention, a dense layer of silk fibroin and biodegradable material is formed on the porous loose layer by electrospinning, and then the silk fibroin is induced to form a β-folded structure by cross-linking. The formed silk-based ultra-thin double-layer membrane has better adhesion to the periodontal tissue. In comparison, the commercially available double-layer collagen membrane feels stiff and has poor adhesion effect.

本发明将天然高分子材料丝素蛋白(SF)、生物可降解材料与无机成分纳米羟基磷灰石(nHA)复合在一起形成复合材料,优势互补,构建丝素基三维结构双层膜。丝素蛋白膜作为主体材料,具有良好的生物降解性和生物相容性;生物可降解材料,具有良好的生物相容性和良好的生物降解性,可与纳米羟基磷灰石共同作为辅助材料,改善丝素蛋白纳米纤维的力学性能不足的缺点,同时提高表面粗糙度和骨诱导性能。The present invention combines natural polymer material silk fibroin (SF), biodegradable material and inorganic component nanohydroxyapatite (nHA) to form a composite material, with complementary advantages, to construct a silk-based three-dimensional double-layer membrane. The silk fibroin membrane, as the main material, has good biodegradability and biocompatibility; the biodegradable material, with good biocompatibility and good biodegradability, can be used together with nanohydroxyapatite as an auxiliary material to improve the shortcomings of insufficient mechanical properties of silk fibroin nanofibers, while improving surface roughness and bone induction performance.

本发明依据材料优化设计和仿生骨膜结构的研究思路进行生物材料的合成设计,将天然材料丝素蛋白和纳米羟基磷灰石复合后纺丝制备得到多孔疏松膜,再在其上纺丝素蛋白/聚L-丙交酯-己内酯致密膜,而后交联,构建了仿生骨膜结构的丝素基三维结构双层膜。该再生膜外层致密,阻挡成纤维细胞长入;内层疏松,有利于成骨细胞粘附和增殖。The present invention carries out the synthesis design of biomaterials based on the research ideas of material optimization design and biomimetic periosteum structure, and prepares a porous loose membrane by spinning the natural material silk fibroin and nano-hydroxyapatite composite, and then spins the silk fibroin/poly-L-lactide-caprolactone dense membrane on it, and then cross-links it to construct a silk fibroin-based three-dimensional double-layer membrane with biomimetic periosteum structure. The outer layer of the regeneration membrane is dense, which blocks the growth of fibroblasts; the inner layer is loose, which is conducive to the adhesion and proliferation of osteoblasts.

优选地,步骤(1)所述含有丝素蛋白与纳米羟基磷灰石的溶液中丝素蛋白与纳米羟基磷灰石的总质量百分比为15%~25%,例如15%、18%、20%、22%、24%或25%。Preferably, the total mass percentage of silk fibroin and nano-hydroxyapatite in the solution containing silk fibroin and nano-hydroxyapatite in step (1) is 15% to 25%, for example, 15%, 18%, 20%, 22%, 24% or 25%.

优选地,步骤(1)所述含有丝素蛋白与纳米羟基磷灰石的溶液的溶剂为六氟异丙醇(HFIP)。Preferably, the solvent of the solution containing silk fibroin and nano-hydroxyapatite in step (1) is hexafluoroisopropanol (HFIP).

优选地,步骤(1)所述含有丝素蛋白与纳米羟基磷灰石的溶液的配制过程为:将冷冻干燥后的丝素蛋白与纳米羟基磷灰石颗粒加入至六氟异丙醇中,得到混合溶液,将混合溶液利用超声波震荡处理,而后搅拌,得到所述含有丝素蛋白与纳米羟基磷灰石的溶液。Preferably, the preparation process of the solution containing silk fibroin and nano-hydroxyapatite in step (1) is: adding freeze-dried silk fibroin and nano-hydroxyapatite particles to hexafluoroisopropanol to obtain a mixed solution, treating the mixed solution with ultrasonic vibration, and then stirring to obtain the solution containing silk fibroin and nano-hydroxyapatite.

优选地,所述超声波震荡处理时的超声功率为19-23KHz,例如19KHz、20KHz、21KHz、22KHz或23KHz,处理时间为10-40min,例如10min、15min、20min、25min、30min、35min或40min。Preferably, the ultrasonic power during the ultrasonic oscillation treatment is 19-23 KHz, for example, 19 KHz, 20 KHz, 21 KHz, 22 KHz or 23 KHz, and the treatment time is 10-40 min, for example, 10 min, 15 min, 20 min, 25 min, 30 min, 35 min or 40 min.

在本发明中,如上所述搅拌可以为磁力搅拌,所述搅拌的时间为3-48小时。In the present invention, the stirring as mentioned above may be magnetic stirring, and the stirring time is 3-48 hours.

优选地,步骤(1)所述静电纺丝时电压设定为10~20kV(例如10kV、13kV、15kV、18kV或20kV),进样速率设定为0.8~1.5mL/h(例如0.8mL/h、1.0mL/h、1.2mL/h或1.5mL/h),利用滚筒接收纤维,滚筒转速为800~3000r/min(例如800r/min、1000r/min、1300r/min、1500r/min、2000r/min、2500r/min或3000r/min),接收距离为10~15cm(例如10cm、11cm、12cm、13cm、14cm或15cm)。Preferably, during the electrospinning in step (1), the voltage is set to 10-20 kV (for example, 10 kV, 13 kV, 15 kV, 18 kV or 20 kV), the feed rate is set to 0.8-1.5 mL/h (for example, 0.8 mL/h, 1.0 mL/h, 1.2 mL/h or 1.5 mL/h), the fiber is received by a roller, the roller speed is 800-3000 r/min (for example, 800 r/min, 1000 r/min, 1300 r/min, 1500 r/min, 2000 r/min, 2500 r/min or 3000 r/min), and the receiving distance is 10-15 cm (for example, 10 cm, 11 cm, 12 cm, 13 cm, 14 cm or 15 cm).

在本发明中,步骤(1)所述静电纺丝液分批次转移到10mL的医用注射器中,给注射器连接上型号为20G的针头,随后将注射器置入静电纺丝装置的推进泵中。In the present invention, the electrospinning solution in step (1) is transferred into a 10 mL medical syringe in batches, a 20G needle is connected to the syringe, and then the syringe is placed in the propulsion pump of the electrospinning device.

优选地,步骤(1)所述静电纺丝在室温下进行,空气湿度为15-20%,例如15%、17%、18%、19%或20%。Preferably, the electrospinning in step (1) is carried out at room temperature, and the air humidity is 15-20%, such as 15%, 17%, 18%, 19% or 20%.

优选地,步骤(2)含有丝素蛋白与生物可降解材料的溶液中丝素蛋白与生物可降解材料的质量百分比为10%~20%,例如10%、13%、15%、18%或20%。Preferably, the mass percentage of silk fibroin and biodegradable material in the solution containing silk fibroin and biodegradable material in step (2) is 10% to 20%, for example, 10%, 13%, 15%, 18% or 20%.

优选地,步骤(2)含有丝素蛋白与生物可降解材料的溶液的溶剂为六氟异丙醇(HFIP)、三氟乙酸(TFA)、乙酸(HAc)或四氢呋喃(THF)中的至少一种。Preferably, the solvent of the solution containing silk fibroin and biodegradable material in step (2) is at least one of hexafluoroisopropanol (HFIP), trifluoroacetic acid (TFA), acetic acid (HAc) or tetrahydrofuran (THF).

优选地,步骤(2)所述含有丝素蛋白与生物可降解材料的溶液的配制过程为:将丝素蛋白与生物可降解材料加入至六氟异丙醇中得到混合溶液,搅拌,得到所述含有丝素蛋白与生物可降解材料的溶液。Preferably, the preparation process of the solution containing silk fibroin and biodegradable material in step (2) is: adding silk fibroin and biodegradable material to hexafluoroisopropanol to obtain a mixed solution, stirring to obtain the solution containing silk fibroin and biodegradable material.

在本发明中,如上所述搅拌可以为磁力搅拌,所述搅拌的时间为3-24小时。优选地,步骤(2)所述静电纺丝时电压设定为10~20kV(例如10kV、13kV、15kV、18kV或20kV),进样速率设定为0.8~1.5mL/h(例如0.8mL/h、1.0mL/h、1.2mL/h或1.5mL/h),利用滚筒接收纤维,滚筒转速为800~3000r/min(例如800r/min、1000r/min、1300r/min、1500r/min、2000r/min、2500r/min或3000r/min),接收距离为10~15cm(例如10cm、11cm、12cm、13cm、14cm或15cm)。In the present invention, the stirring as described above can be magnetic stirring, and the stirring time is 3-24 hours. Preferably, during the electrostatic spinning in step (2), the voltage is set to 10-20 kV (e.g., 10 kV, 13 kV, 15 kV, 18 kV or 20 kV), the injection rate is set to 0.8-1.5 mL/h (e.g., 0.8 mL/h, 1.0 mL/h, 1.2 mL/h or 1.5 mL/h), and the fiber is received by a drum, and the drum speed is 800-3000 r/min (e.g., 800 r/min, 1000 r/min, 1300 r/min, 1500 r/min, 2000 r/min, 2500 r/min or 3000 r/min), and the receiving distance is 10-15 cm (e.g., 10 cm, 11 cm, 12 cm, 13 cm, 14 cm or 15 cm).

在本发明中,步骤(2)所述静电纺丝液分批次转移到10mL的医用注射器中,给注射器连接上型号为20G的针头,随后将注射器置入静电纺丝装置的推进泵中。In the present invention, the electrospinning solution in step (2) is transferred in batches into a 10 mL medical syringe, a 20G needle is connected to the syringe, and then the syringe is placed in the propulsion pump of the electrospinning device.

优选地,步骤(2)所述静电纺丝在室温下进行,空气湿度为15-20%,例如15%、17%、18%、19%或20%。Preferably, the electrospinning in step (2) is carried out at room temperature, and the air humidity is 15-20%, such as 15%, 17%, 18%, 19% or 20%.

优选地,步骤(3)所述交联剂为碳化二亚胺盐(EDC)和羟基丁二酰亚胺(NHS)。Preferably, the cross-linking agent in step (3) is diimide carbohydrate (EDC) and hydroxysuccinimide (NHS).

优选地,所述碳化二亚胺盐和羟基丁二酰亚胺的质量比为20%~30%,例如20%、23%、25%、28%或30%。Preferably, the mass ratio of the carbodiimide salt to hydroxysuccinimide is 20% to 30%, for example, 20%, 23%, 25%, 28% or 30%.

优选地,步骤(3)所述交联在室温下进行,所述交联的时间为1-6小时,例如1小时、2小时、3小时、4小时、5小时或6小时。Preferably, the cross-linking in step (3) is carried out at room temperature, and the cross-linking time is 1-6 hours, for example 1 hour, 2 hours, 3 hours, 4 hours, 5 hours or 6 hours.

优选地,步骤(3)所述交联在有机溶剂中进行,所述有机溶剂为无水乙醇。Preferably, the crosslinking in step (3) is carried out in an organic solvent, and the organic solvent is anhydrous ethanol.

优选地,步骤(3)在交联前,将步骤(2)得到的双层膜进行干燥,除去膜上残留的有机溶剂。Preferably, in step (3), before cross-linking, the double-layer membrane obtained in step (2) is dried to remove the organic solvent remaining on the membrane.

在步骤(3)交联后,用去离子水将残留交联剂冲洗干净后置于冷冻干燥机中干燥。After cross-linking in step (3), the residual cross-linking agent is rinsed with deionized water and then placed in a freeze dryer for drying.

另一方面,本发明提供了如上所述用于牙周再生的丝素基三维结构双层膜在口腔种植材料制备中的应用。On the other hand, the present invention provides the use of the silk-based three-dimensional structured double-layer membrane for periodontal regeneration as described above in the preparation of oral implant materials.

相对于现有技术,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:

在本发明中,将丝素蛋白与纳米羟基磷灰石(nano-hydroxyapatite,nHA)复合,增加表面粗糙度并大幅提高机械强度。此外,添加高分子生物可降解材料可以进一步增加纳米纤维膜的稳定性和力学强度。多孔疏松层和外层的致密层形成交联结构,能够诱导丝素蛋白形成β-折叠结构,使得本发明的牙周再生的丝素基双层膜具有三维结构,作为口腔修复膜,其致密层具有良好的机械屏障作用,疏松层起到诱导骨组织再生作用,实现双层结构的同时仍具有“超薄”的物理特性,膜结构更为柔软与牙周组织更好贴合,在临床手术过程中操作更为便利,实现超薄结构的同时仍具有较好的力学性能和降解性能。并且本发明的制备方法操作简单,实验制备条件温和的优点,适于大规模批量生产,具有较好的应用前景。In the present invention, silk fibroin is compounded with nano-hydroxyapatite (nHA) to increase surface roughness and greatly improve mechanical strength. In addition, adding high molecular biodegradable materials can further increase the stability and mechanical strength of nanofiber membranes. The porous loose layer and the outer dense layer form a cross-linked structure, which can induce silk fibroin to form a β-folded structure, so that the silk fibroin-based double-layer membrane of periodontal regeneration of the present invention has a three-dimensional structure. As an oral repair membrane, its dense layer has a good mechanical barrier effect, and the loose layer plays an inducing bone tissue regeneration effect. While realizing the double-layer structure, it still has the physical properties of "ultra-thin", and the membrane structure is softer and better fits the periodontal tissue. It is more convenient to operate during clinical surgery, and it still has good mechanical properties and degradation performance while realizing the ultra-thin structure. And the preparation method of the present invention is simple to operate, and the advantages of mild experimental preparation conditions are suitable for large-scale batch production, and have good application prospects.

附图说明BRIEF DESCRIPTION OF THE DRAWINGS

图1为实施例3制备得到的丝素基三维结构双层膜的结构示意图和扫描电镜图,其中(A)丝素基三维结构双层膜的结构示意图,其包括一层疏松面(其中小球代表纳米羟基磷灰石)和一层致密面,(B)内层nHA@SF纳米纤维膜的扫描电镜图,标尺为10μm,(C)外层5SF/5P纳米纤维膜的扫描电镜图,标尺为10μm,(D)nHA@SF-5SF/5P双层纳米纤维膜横切面的扫描电镜图,标尺为10μm;Figure 1 is a schematic diagram and scanning electron microscope image of the structure of the silk-based three-dimensional structure double-layer membrane prepared in Example 3, wherein (A) a schematic diagram of the structure of the silk-based three-dimensional structure double-layer membrane, which includes a loose surface (wherein the small spheres represent nanohydroxyapatite) and a dense surface, (B) a scanning electron microscope image of the inner layer nHA@SF nanofiber membrane, with a scale of 10 μm, (C) a scanning electron microscope image of the outer layer 5SF/5P nanofiber membrane, with a scale of 10 μm, (D) a scanning electron microscope image of the cross section of the nHA@SF-5SF/5P double-layer nanofiber membrane, with a scale of 10 μm;

图2为实施例3制备得到的膜的红外图谱,(A)多孔疏松膜nHA@SF的红外图谱,(B)致密膜5SF/5P的红外图谱;FIG2 is the infrared spectra of the films prepared in Example 3, (A) the infrared spectrum of the porous loose film nHA@SF, (B) the infrared spectrum of the dense film 5SF/5P;

图3为实施例3制备得到的膜的X射线衍射图谱;FIG3 is an X-ray diffraction pattern of the film prepared in Example 3;

图4为实施例3制备得到的膜的接触角测试结果;FIG4 is a contact angle test result of the film prepared in Example 3;

图5为实施例1-3制备得到的丝素基三维结构双层膜的力学性能测试结果图,(A)应力-应变曲线,(B)断裂强度测试结果图,(C)断裂伸长率测试结果图,(D)杨氏模量测试结果图;FIG5 is a graph showing the mechanical properties test results of the silk-based three-dimensional structured double-layer membrane prepared in Examples 1-3, (A) stress-strain curve, (B) breaking strength test result graph, (C) breaking elongation test result graph, and (D) Young's modulus test result graph;

图6为实施例3、实施例4、实施例5制备得到的内层纳米纤维膜的扫描电镜图,其中(A)为实施例3制备得到的内层纳米纤维膜的扫描电镜图,标尺为10μm,(B)为实施例4制备得到的内层纳米纤维膜的扫描电镜图,标尺为10μm,(C)为实施例5制备得到的内层纳米纤维膜的扫描电镜图,标尺为10μm;Figure 6 is a scanning electron microscope image of the inner nanofiber membrane prepared in Example 3, Example 4, and Example 5, wherein (A) is a scanning electron microscope image of the inner nanofiber membrane prepared in Example 3, with a scale of 10 μm, (B) is a scanning electron microscope image of the inner nanofiber membrane prepared in Example 4, with a scale of 10 μm, and (C) is a scanning electron microscope image of the inner nanofiber membrane prepared in Example 5, with a scale of 10 μm;

图7为实施例2和对比例1制备得到的膜的体外降解曲线;FIG7 is an in vitro degradation curve of the membranes prepared in Example 2 and Comparative Example 1;

图8为实施例2和对比例2制备得到的膜的扫描电镜图;FIG8 is a scanning electron microscope image of the films prepared in Example 2 and Comparative Example 2;

图9为实施例1和对比例3制备得到的膜的表面拍摄图。FIG. 9 is a surface photograph of the films prepared in Example 1 and Comparative Example 3.

具体实施方式Detailed ways

下面通过具体实施方式来进一步说明本发明的技术方案。本领域技术人员应该明了,所述实施例仅仅是帮助理解本发明,不应视为对本发明的具体限制。The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only used to help understand the present invention and should not be regarded as specific limitations of the present invention.

在本发明的实施例中使用的丝素蛋白的制备方法为:将40g天然家蚕丝放入2L浓度为0.05%的碳酸钠溶液中煮沸处理30min,重复三次,用去离子水充分洗涤干净后烘干得到家蚕丝素纤维。然后将丝素纤维以1:10的浴比溶解在9.3mol/L的溴化锂(LiBr)溶液中,于60℃中搅拌1h得到丝素蛋白混合溶液。待混合溶液冷却后,将混合溶液装入透析袋(截留分子量8-12kD),用去离子水透析5天,每12h换一次水,透析完后过滤得到丝素蛋白溶液。将丝素蛋白溶液置于-80℃冰箱,随后冷冻干燥获得丝素蛋白。The preparation method of the silk fibroin used in the embodiment of the present invention is as follows: 40g of natural silkworm silk is placed in 2L of sodium carbonate solution with a concentration of 0.05% and boiled for 30min, repeated three times, and then fully washed with deionized water and dried to obtain silkworm silk fiber. Then the silk fiber is dissolved in a 9.3mol/L lithium bromide (LiBr) solution with a bath ratio of 1:10, and stirred at 60°C for 1h to obtain a silk fibroin mixed solution. After the mixed solution is cooled, the mixed solution is loaded into a dialysis bag (molecular weight cutoff 8-12kD), dialyzed with deionized water for 5 days, changing the water every 12h, and filtered after the dialysis to obtain a silk fibroin solution. The silk fibroin solution is placed in a -80°C refrigerator, and then freeze-dried to obtain silk fibroin.

实施例1Example 1

本实施例提供一种丝素基三维结构双层膜及其制备方法,所述制备方法包括以下步骤:This embodiment provides a silk fibroin-based three-dimensional structure double-layer membrane and a preparation method thereof, the preparation method comprising the following steps:

(1)多孔疏松膜的制备方法为:将冷冻干燥后的丝素蛋白与纳米羟基磷灰石颗粒以质量比5:1溶解在10mL六氟异丙醇(HFIP)中,配置成质量体积比为15%的混合溶液,超声波震荡处理30min使其分散,在室温条件下用磁力搅拌器搅拌24小时后得到乳白色的SF/nHA静电纺丝液。将SF/nHA静电纺丝液分批次转移到10mL的医用注射器中,给注射器连接上型号为20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.0mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为1000r/min,接收距离固定为12cm。整个过程都在室温条件下进行,空气湿度为15-20%,制备的单层膜命名为nHA@SF。(1) The preparation method of the porous loose membrane is as follows: the freeze-dried silk fibroin and nano-hydroxyapatite particles are dissolved in 10 mL of hexafluoroisopropanol (HFIP) at a mass ratio of 5:1 to prepare a mixed solution with a mass volume ratio of 15%, and the mixture is dispersed by ultrasonic oscillation for 30 minutes. After stirring with a magnetic stirrer for 24 hours at room temperature, a milky SF/nHA electrospinning solution is obtained. The SF/nHA electrospinning solution is transferred to a 10 mL medical syringe in batches, and a 20G needle is connected to the syringe. The syringe is then placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15 kV, the propulsion pump rate is set to 1.0 mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the rotation speed is 1000 r/min, and the receiving distance is fixed to 12 cm. The whole process is carried out at room temperature, the air humidity is 15-20%, and the prepared single-layer membrane is named nHA@SF.

(2)致密膜的制备方法为:取丝素蛋白溶解于六氟异丙醇中,配置成质量体积比为15%的混合溶液。在室温条件下用磁力搅拌器搅拌12小时后得到澄清透明的SF静电纺丝液。将SF静电纺丝液转移到10mL的医用注射器中,给注射器连接上型号为20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.2mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为1000r/min,接收距离固定为15cm。整个过程都在室温条件下进行,空气湿度为15-20%。该步骤制备的单层膜命名为10SF。(2) The preparation method of the dense membrane is as follows: silk fibroin is dissolved in hexafluoroisopropanol to prepare a mixed solution with a mass volume ratio of 15%. After stirring with a magnetic stirrer for 12 hours at room temperature, a clear and transparent SF electrospinning solution is obtained. The SF electrospinning solution is transferred to a 10mL medical syringe, a 20G needle is connected to the syringe, and then the syringe is placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15kV, the propulsion pump rate is set to 1.2mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the speed is 1000r/min, and the receiving distance is fixed to 15cm. The whole process is carried out at room temperature and the air humidity is 15-20%. The single-layer membrane prepared in this step is named 10SF.

(3)基于丝素蛋白的纳米纤维双层膜的制备方法为:在SF/nHA层形成的多孔疏松膜基础上再纺SF/PLCL层致密膜,形成丝素基三维结构双层膜。制备的双层膜命名为nHA@SF-10SF。纺丝完毕后将电纺膜放置于真空干燥箱48小时除去膜上残留的有机溶剂,随后于EDC-NHS交联剂溶液(EDC:NHS质量比为2:1溶于无水乙醇中,EDC-NHS与无水乙醇的质量体积比为3:10)中交联4h,用去离子水将残留交联剂冲洗干净后置于冷冻干燥机中,最终干燥的丝素基三维结构双层膜。(3) The preparation method of the nanofiber double-layer membrane based on silk fibroin is as follows: on the basis of the porous loose membrane formed by the SF/nHA layer, the SF/PLCL layer of dense membrane is spun to form a silk-based three-dimensional structure double-layer membrane. The prepared double-layer membrane is named nHA@SF-10SF. After spinning, the electrospun membrane is placed in a vacuum drying oven for 48 hours to remove the residual organic solvent on the membrane, and then cross-linked in an EDC-NHS cross-linker solution (EDC: NHS mass ratio is 2:1 dissolved in anhydrous ethanol, and the mass volume ratio of EDC-NHS to anhydrous ethanol is 3:10) for 4 hours, and the residual cross-linker is rinsed with deionized water and placed in a freeze dryer to finally dry the silk-based three-dimensional structure double-layer membrane.

实施例2Example 2

本实施例提供一种丝素基三维结构双层膜及其制备方法,所述制备方法包括以下步骤:This embodiment provides a silk fibroin-based three-dimensional structure double-layer membrane and a preparation method thereof, the preparation method comprising the following steps:

(1)多孔疏松膜的制备方法为:将冷冻干燥后的丝素蛋白与纳米羟基磷灰石颗粒以质量比5:1溶解在10mL六氟异丙醇(HFIP)中,配置成质量体积比为15%的混合溶液。超声波震荡处理30min使其分散,在室温条件下用磁力搅拌器搅拌24小时后得到乳白色的SF/nHA静电纺丝液。将SF/nHA静电纺丝液分批次转移到10mL的医用注射器中,给注射器连接上型号为20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.0mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为1000r/min,接收距离固定为12cm。整个过程都在室温条件下进行,空气湿度为15-20%,制备的单层膜命名为nHA@SF。(1) The preparation method of the porous loose membrane is as follows: freeze-dried silk fibroin and nano-hydroxyapatite particles are dissolved in 10 mL of hexafluoroisopropanol (HFIP) at a mass ratio of 5:1 to prepare a mixed solution with a mass volume ratio of 15%. Ultrasonic oscillation treatment is performed for 30 minutes to disperse them, and a milky SF/nHA electrospinning solution is obtained after stirring with a magnetic stirrer for 24 hours at room temperature. The SF/nHA electrospinning solution is transferred into a 10 mL medical syringe in batches, and a 20G needle is connected to the syringe. The syringe is then placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15 kV, the propulsion pump rate is set to 1.0 mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the rotation speed is 1000 r/min, and the receiving distance is fixed to 12 cm. The entire process is carried out at room temperature, the air humidity is 15-20%, and the prepared single-layer membrane is named nHA@SF.

(2)致密膜的制备方法为:分别取丝素蛋白和聚L-丙交酯-己内酯以质量比分别为8:2比例溶解六氟异丙醇中,配置成质量体积比为15%的混合溶液。在室温条件下用磁力搅拌器搅拌12小时后得到澄清透明的SF/PLCL静电纺丝液。将SF/PLCL静电纺丝液转移到10mL的医用注射器中,给注射器连接上型号20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.2mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为1000r/min,接收距离固定为15cm。整个过程都在室温条件下进行,空气湿度为15~20%。该步骤制备的单层膜命名为8SF/2P。(2) The preparation method of the dense membrane is as follows: silk fibroin and poly (L-lactide-caprolactone) are dissolved in hexafluoroisopropanol in a mass ratio of 8:2, respectively, to prepare a mixed solution with a mass volume ratio of 15%. After stirring with a magnetic stirrer for 12 hours at room temperature, a clear and transparent SF/PLCL electrospinning solution is obtained. The SF/PLCL electrospinning solution is transferred to a 10mL medical syringe, a 20G needle is connected to the syringe, and then the syringe is placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15kV, the propulsion pump rate is set to 1.2mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the rotation speed is 1000r/min, and the receiving distance is fixed to 15cm. The whole process is carried out at room temperature and the air humidity is 15-20%. The single-layer membrane prepared in this step is named 8SF/2P.

(3)基于丝素蛋白的纳米纤维双层膜的制备方法为:在SF/nHA层形成的多孔疏松膜基础上再纺SF/PLCL层致密膜,形成丝素基三维结构双层膜。制备的双层膜分别命名为nHA@SF-8SF/2P。纺丝完毕后将电纺膜放置于真空干燥箱48小时除去膜上残留的有机溶剂,随后于EDC-NHS交联剂溶液(EDC:NHS质量比为2:1溶于无水乙醇中,EDC-NHS与无水乙醇的质量体积比为3:10)中交联4h,溶剂为无水乙醇,用去离子水将残留交联剂冲洗干净后置于冷冻干燥机中,最终干燥的丝素基三维结构双层膜。(3) The preparation method of the nanofiber double-layer membrane based on silk fibroin is as follows: on the basis of the porous loose membrane formed by the SF/nHA layer, the SF/PLCL layer of dense membrane is spun to form a silk-based three-dimensional structure double-layer membrane. The prepared double-layer membranes are named nHA@SF-8SF/2P. After spinning, the electrospun membrane is placed in a vacuum drying oven for 48 hours to remove the residual organic solvent on the membrane, and then cross-linked in an EDC-NHS cross-linker solution (EDC: NHS mass ratio is 2:1 dissolved in anhydrous ethanol, and the mass volume ratio of EDC-NHS to anhydrous ethanol is 3:10) for 4 hours, the solvent is anhydrous ethanol, the residual cross-linker is rinsed with deionized water and placed in a freeze dryer, and finally the silk-based three-dimensional structure double-layer membrane is dried.

实施例3Example 3

本实施例提供一种丝素基三维结构双层膜及其制备方法,所述制备方法包括以下步骤:This embodiment provides a silk fibroin-based three-dimensional structure double-layer membrane and a preparation method thereof, the preparation method comprising the following steps:

(1)多孔疏松膜的制备方法为:将冷冻干燥后的丝素蛋白与纳米羟基磷灰石颗粒以质量比5:1溶解在10mL六氟异丙醇(HFIP)中,配置成质量体积比为15%的混合溶液。超声波震荡处理30min使其分散,在室温条件下用磁力搅拌器搅拌24小时后得到乳白色的SF/nHA静电纺丝液。将SF/nHA静电纺丝液分批次转移到10mL的医用注射器中,给注射器连接上型号维20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.0mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为3000r/min,接收距离固定为12cm。整个过程都在室温条件下进行,空气湿度为15-20%,制备的单层膜命名为nHA@SF。(1) The preparation method of the porous loose membrane is as follows: freeze-dried silk fibroin and nano-hydroxyapatite particles are dissolved in 10 mL of hexafluoroisopropanol (HFIP) at a mass ratio of 5:1 to prepare a mixed solution with a mass volume ratio of 15%. Ultrasonic oscillation treatment is performed for 30 minutes to disperse them, and a milky SF/nHA electrospinning solution is obtained after stirring with a magnetic stirrer for 24 hours at room temperature. The SF/nHA electrospinning solution is transferred into a 10 mL medical syringe in batches, and a 20G needle is connected to the syringe. The syringe is then placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15 kV, the propulsion pump rate is set to 1.0 mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the rotation speed is 3000 r/min, and the receiving distance is fixed to 12 cm. The whole process is carried out at room temperature, the air humidity is 15-20%, and the prepared single-layer membrane is named nHA@SF.

(2)致密膜的制备方法为:分别取丝素蛋白和聚L-丙交酯-己内酯以质量比分别为5:5比例溶解六氟异丙醇中,配置成质量体积比为15%的混合溶液。在室温条件下用磁力搅拌器搅拌12小时后得到澄清透明的SF/PLCL静电纺丝液。将SF/PLCL静电纺丝液转移到10mL的医用注射器中,给注射器连接上型号维20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.2mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为3000r/min,接收距离固定为15cm。整个过程都在室温条件下进行,空气湿度为15~20%。该步骤制备的单层膜命名为5SF/5P。(2) The preparation method of the dense membrane is as follows: silk fibroin and poly (L-lactide-caprolactone) are dissolved in hexafluoroisopropanol at a mass ratio of 5:5, respectively, to prepare a mixed solution with a mass volume ratio of 15%. After stirring with a magnetic stirrer for 12 hours at room temperature, a clear and transparent SF/PLCL electrospinning solution is obtained. The SF/PLCL electrospinning solution is transferred to a 10mL medical syringe, a 20G needle is connected to the syringe, and then the syringe is placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15kV, the propulsion pump rate is set to 1.2mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the rotation speed is 3000r/min, and the receiving distance is fixed to 15cm. The whole process is carried out at room temperature and the air humidity is 15-20%. The single-layer membrane prepared in this step is named 5SF/5P.

(3)基于丝素蛋白的纳米纤维双层膜的制备方法为:在SF/nHA层形成的多孔疏松膜基础上再纺SF/PLCL层致密膜,形成丝素基三维结构双层膜。制备的双层膜分别命名为nHA@SF-5SF/5P。纺丝完毕后将电纺膜放置于真空干燥箱48小时除去膜上残留的有机溶剂,随后于EDC-NHS交联剂溶液(EDC:NHS质量比为2:1溶于无水乙醇中,EDC-NHS与无水乙醇的质量体积比为3:10)中交联4h,溶剂为无水乙醇,用去离子水将残留交联剂冲洗干净后置于冷冻干燥机中,最终干燥的丝素基三维结构双层膜。(3) The preparation method of the nanofiber double-layer membrane based on silk fibroin is as follows: on the basis of the porous loose membrane formed by the SF/nHA layer, a dense membrane of the SF/PLCL layer is spun to form a silk-based three-dimensional structure double-layer membrane. The prepared double-layer membranes are named nHA@SF-5SF/5P. After spinning, the electrospun membrane is placed in a vacuum drying oven for 48 hours to remove the residual organic solvent on the membrane, and then cross-linked in an EDC-NHS cross-linker solution (EDC: NHS mass ratio is 2:1 dissolved in anhydrous ethanol, and the mass volume ratio of EDC-NHS to anhydrous ethanol is 3:10) for 4 hours, the solvent is anhydrous ethanol, the residual cross-linker is rinsed with deionized water and placed in a freeze dryer, and finally the silk-based three-dimensional structure double-layer membrane is dried.

本发明制备得到的丝素基三维结构双层膜的结构示意图如图1中A所示,本实施例制备得到的外层5SF/5P纳米纤维膜的扫描电镜(Hitachi,TM-1000)图如图1中B所示,内层nHA@SF纳米纤维膜的扫描电镜图如图1中C所示,丝素基三维结构双层膜的扫描电镜图如图1中D所示,由图可以看出,在nHA@SF纳米纤维膜表面含有羟基磷灰石的纤维上观察到了突起的鼓包或者结节,而掺杂了羟基磷灰石的纳米纤维膜的孔隙率高于未掺杂的纳米纤维膜。侧切图结果表明nHA@SF较为疏松,而5SF/5P较为致密,且两层之间结合紧密度较高。The schematic diagram of the structure of the silk-based three-dimensional structure double-layer membrane prepared by the present invention is shown in Figure 1A, the scanning electron microscope (Hitachi, TM-1000) image of the outer layer 5SF/5P nanofiber membrane prepared in this embodiment is shown in Figure 1B, the scanning electron microscope image of the inner layer nHA@SF nanofiber membrane is shown in Figure 1C, and the scanning electron microscope image of the silk-based three-dimensional structure double-layer membrane is shown in Figure 1D. It can be seen from the figure that protruding bulges or nodules are observed on the fibers containing hydroxyapatite on the surface of the nHA@SF nanofiber membrane, and the porosity of the nanofiber membrane doped with hydroxyapatite is higher than that of the undoped nanofiber membrane. The side-section results show that nHA@SF is relatively loose, while 5SF/5P is relatively dense, and the bonding between the two layers is relatively tight.

测量纳米纤维膜的厚度取平均,所得数据如下表1所示。在实现双层结构的同时仍具有较小的厚度,预计在临床使用过程中能够较好的贴合牙周组织。The thickness of the nanofiber membrane was measured and averaged, and the obtained data is shown in the following Table 1. While achieving a double-layer structure, it still has a small thickness, and it is expected to be able to better fit the periodontal tissue during clinical use.

表1Table 1

实施例1Example 1 0.1093mm0.1093mm 实施例2Example 2 0.0982mm0.0982mm 实施例3Example 3 0.9734mm0.9734mm

利用红外(Thermo Fisher,NicoletiN 10)对制备得到的膜进行了表征,图2为纳米纤维膜的红外图谱,其中(A)内层nHA@SF纳米纤维膜,(B)外层5SF/5P纳米纤维膜;由图可以看出,根据吸收峰的位置和强度,可以验证丝素基纳米纤维双层膜的化学组成。具体而言,所有含有丝素(SF)的纳米纤维膜在1623cm-1、1518cm-1和1233cm-1处表现出明显的吸收峰,分别对应SF中的Silk-I和Silk-II(N-H)和Silk-III(C-N)。在负载了纳米羟基磷灰石(nHA)之后,nHA/SF和PLCL/SF/nHA复合膜在1045cm-1处出现吸收峰,表明膜中存在P-O键,而在601cm-1处出现的吸收峰则源于nHA中的O-P-O磷酸基团,这些结果证实了nHA成功地加载到SF/PLCL/nHA复合膜中。此外,在1752cm-1处观察到了强吸收峰,对应了聚乳酸(PLA)酯羰基的典型不对称拉伸。位于2995cm-1和2945cm-1的吸收峰则分别属于PLA的不对称和对称的C-H拉伸震动。1454cm-1和1382cm-1的吸收峰属于PLA对称和不对称弯曲的C-H变形。1181cm-1、1130cm-1和1085cm-1处的峰值则是因为PLA的C-O拉伸。综上所述,通过FTIR图谱分析可以得出结论:制备的丝素基纳米纤维双层膜具有组成物质基本的特征基团,且成功地负载了nHA。The prepared membranes were characterized by infrared (Thermo Fisher, NicoletiN 10). Figure 2 shows the infrared spectrum of the nanofiber membranes, including (A) inner layer nHA@SF nanofiber membrane, (B) outer layer 5SF/5P nanofiber membrane; it can be seen from the figure that the chemical composition of the silk-based nanofiber double-layer membrane can be verified according to the position and intensity of the absorption peaks. Specifically, all nanofiber membranes containing silk (SF) show obvious absorption peaks at 1623cm -1 , 1518cm -1 and 1233cm -1 , corresponding to Silk-I and Silk-II (NH) and Silk-III (CN) in SF, respectively. After loading nanohydroxyapatite (nHA), nHA/SF and PLCL/SF/nHA composite membranes show absorption peaks at 1045cm -1 , indicating the presence of PO bonds in the membranes, while the absorption peak at 601cm -1 is derived from the OPO phosphate group in nHA. These results confirm that nHA is successfully loaded into the SF/PLCL/nHA composite membrane. In addition, a strong absorption peak was observed at 1752cm -1 , corresponding to the typical asymmetric stretching of the carbonyl group of polylactic acid (PLA). The absorption peaks at 2995cm -1 and 2945cm -1 belong to the asymmetric and symmetric CH stretching vibrations of PLA, respectively. The absorption peaks at 1454cm -1 and 1382cm -1 belong to the symmetric and asymmetric bending CH deformation of PLA. The peaks at 1181cm -1 , 1130cm -1 and 1085cm -1 are due to the CO stretching of PLA. In summary, the FTIR spectrum analysis can conclude that the prepared silk-based nanofiber double-layer membrane has the basic characteristic groups of the constituent substances and has successfully loaded nHA.

利用X射线衍射(Rigaku,D/max-2550PC)对制备得到的膜进行了表征,结果如图3所示,由图可以看出,纯PLCL材料的XRD图谱中出现了两个主要特征衍射峰,分别位于2θ=16.7°和19.0°处,这表明PLCL中存在典型的半晶体结构。这是由于PLCL所用溶剂为HFIP,HFIP对于PLCL是一种良性溶剂。在稀溶液中,PLCL分子链可以完全被HFIP分子所包围,分子链彼此无关,高分子在溶液中以孤立线团形式存在,减少了聚合物之间的接触,分子链完全伸展,避免了互相缠结,这些伸展聚合物链趋向有序排列。而掺杂了SF和nHA的纤维膜没有出现尖峰,说明这些复合材料没有明显的晶体结构。PLCL和SF大部分都以无定型结构存在于纤维膜中,只有少部分有序结构以宽峰的形式展现出来。在PLCL和SF复合之后,部分聚合物链的有序结构被打乱。The prepared membrane was characterized by X-ray diffraction (Rigaku, D/max-2550PC), and the results are shown in Figure 3. It can be seen from the figure that two main characteristic diffraction peaks appeared in the XRD spectrum of pure PLCL material, located at 2θ=16.7° and 19.0°, respectively, which indicates that there is a typical semi-crystalline structure in PLCL. This is because the solvent used for PLCL is HFIP, which is a benign solvent for PLCL. In dilute solution, the PLCL molecular chain can be completely surrounded by HFIP molecules, and the molecular chains are independent of each other. The polymer exists in the solution in the form of isolated coils, which reduces the contact between polymers. The molecular chains are fully extended to avoid mutual entanglement, and these extended polymer chains tend to be arranged in an orderly manner. However, the fiber membrane doped with SF and nHA did not show sharp peaks, indicating that these composite materials have no obvious crystalline structure. Most of PLCL and SF exist in the fiber membrane as amorphous structures, and only a small part of the ordered structure is displayed in the form of broad peaks. After PLCL and SF are compounded, the ordered structure of some polymer chains is disrupted.

利用接触角测量仪(Kruss,DSA-30)对制备得到的膜进行了接触角测试,结果如图4所示,可以看出,10SF、8SF/2P、5SF/5P和nHA@SF的接触角分别为74.76°±3.22°、98.76°±1.72°、108.69°±2.49°、67.72°±2.29°。通过实验结果可以得出,随着SF含量占比的减少,丝素基纳米纤维双层膜的疏水性增加。因为SF中的羟基可以与水分子形成氢键,使得膜表面具有较为显著的亲水性。同时,nHA@SF由于nHA加入使得表面粗糙程度大,且在用静电纺制备nHA@SF时参数设置上使得该层膜本身就有较大的孔隙率,故最为亲水。薄膜材料具有不同粗糙度和表面积,产生的表面张力将不同,这对接触角有影响。通常当接触角小于90°时,粗糙面的较大作用面积和表面张力更大,更容易润湿。实验结果显示,10SF、nHA@SF接触角小于90°,8SF/2P、5SF/5P接触角也接近90°,因此该实验制备的双层膜内外两层都具有较好的亲水性,对于细胞在膜表面的粘附、生长和繁殖具有一定程度的帮助。The contact angle of the prepared membrane was tested using a contact angle meter (Kruss, DSA-30). The results are shown in Figure 4. It can be seen that the contact angles of 10SF, 8SF/2P, 5SF/5P and nHA@SF are 74.76°±3.22°, 98.76°±1.72°, 108.69°±2.49°, and 67.72°±2.29°, respectively. The experimental results show that as the proportion of SF content decreases, the hydrophobicity of the silk-based nanofiber double-layer membrane increases. Because the hydroxyl groups in SF can form hydrogen bonds with water molecules, the membrane surface has a more significant hydrophilicity. At the same time, nHA@SF has a large surface roughness due to the addition of nHA, and the parameters set when preparing nHA@SF by electrospinning make the membrane itself have a large porosity, so it is the most hydrophilic. The film materials have different roughness and surface area, and the surface tension generated will be different, which will affect the contact angle. Generally, when the contact angle is less than 90°, the rough surface has a larger effective area and greater surface tension, making it easier to wet. The experimental results show that the contact angles of 10SF and nHA@SF are less than 90°, and the contact angles of 8SF/2P and 5SF/5P are also close to 90°. Therefore, both the inner and outer layers of the double-layer membrane prepared in this experiment have good hydrophilicity, which is helpful to a certain extent for the adhesion, growth and reproduction of cells on the membrane surface.

对实施例1-3得到的丝素基三维结构双层膜利用电脑式拉压力试验机(上海恒驭,HY-940FS)进行了力学性能的测试,如图5所示。其中(A)应力-应变曲线,(B)断裂强度,(C)断裂伸长率,(D)杨氏模量;适量PLCL的加入能显著增强纤维膜的断裂韧性。不含PLCL的nHA@SF-10SF组最大拉伸强度值为2.576MPa,而SF与PLCL比例为5:5的nHA@SF-5SF/5P为最大拉伸强度为1.455MPa,PLCL一定程度上削弱了拉伸强度。通过本实验结果可以得出,适量添加PLCL可以提高丝素纳米纤维复合膜的力学性能,而过多的PLCL添加则会对其力学性能造成一定的负面影响。因此,对于丝素纳米纤维复合膜的制备,需要在保证力学性能的同时,适当控制PLCL的加入量。The mechanical properties of the silk-based three-dimensional structure double-layer membrane obtained in Example 1-3 were tested using a computerized tensile and pressure testing machine (Shanghai Hengyu, HY-940FS), as shown in Figure 5. Among them, (A) stress-strain curve, (B) breaking strength, (C) elongation at break, (D) Young's modulus; the addition of an appropriate amount of PLCL can significantly enhance the fracture toughness of the fiber membrane. The maximum tensile strength value of the nHA@SF-10SF group without PLCL is 2.576MPa, while the maximum tensile strength of the nHA@SF-5SF/5P with a ratio of SF to PLCL of 5:5 is 1.455MPa, and PLCL weakens the tensile strength to a certain extent. It can be concluded from the experimental results that the addition of PLCL in an appropriate amount can improve the mechanical properties of the silk nanofiber composite membrane, while the addition of too much PLCL will have a certain negative impact on its mechanical properties. Therefore, for the preparation of silk nanofiber composite membranes, it is necessary to properly control the amount of PLCL added while ensuring the mechanical properties.

实施例4Example 4

本实施例提供一种丝素基三维结构双层膜及其制备方法,所述制备方法包括以下步骤:This embodiment provides a silk fibroin-based three-dimensional structure double-layer membrane and a preparation method thereof, the preparation method comprising the following steps:

(1)多孔疏松膜的制备方法为:将冷冻干燥后的丝素蛋白与纳米羟基磷灰石颗粒以质量比4:1溶解在10mL六氟异丙醇(HFIP)中,配置成质量体积比为15%的混合溶液。超声波震荡处理30min使其分散,在室温条件下用磁力搅拌器搅拌24小时后得到乳白色的SF/nHA静电纺丝液。将SF/nHA静电纺丝液分批次转移到10mL的医用注射器中,给注射器连接上型号为20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.0mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为1000r/min,接收距离固定为12cm。整个过程都在室温条件下进行,空气湿度为15-20%,制备的单层膜命名为nHA@SF。(1) The preparation method of the porous loose membrane is as follows: the freeze-dried silk fibroin and nano-hydroxyapatite particles are dissolved in 10 mL of hexafluoroisopropanol (HFIP) at a mass ratio of 4:1 to prepare a mixed solution with a mass volume ratio of 15%. The mixture is dispersed by ultrasonic oscillation for 30 minutes, and a milky SF/nHA electrospinning solution is obtained after stirring with a magnetic stirrer for 24 hours at room temperature. The SF/nHA electrospinning solution is transferred into a 10 mL medical syringe in batches, and a 20G needle is connected to the syringe. The syringe is then placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15 kV, the propulsion pump rate is set to 1.0 mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the rotation speed is 1000 r/min, and the receiving distance is fixed to 12 cm. The whole process is carried out at room temperature, the air humidity is 15-20%, and the prepared single-layer membrane is named nHA@SF.

(2)致密膜的制备方法为:分别取丝素蛋白和聚L-丙交酯-己内酯以质量比分别为8:2比例溶解六氟异丙醇中,配置成质量体积比为15%的混合溶液。在室温条件下用磁力搅拌器搅拌12小时后得到澄清透明的SF/PLCL静电纺丝液。将SF/PLCL静电纺丝液转移到10mL的医用注射器中,给注射器连接上型号20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.2mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为1000r/min,接收距离固定为15cm。整个过程都在室温条件下进行,空气湿度为15~20%。该步骤制备的单层膜命名为8SF/2P。(2) The preparation method of the dense membrane is as follows: silk fibroin and poly (L-lactide-caprolactone) are dissolved in hexafluoroisopropanol in a mass ratio of 8:2, respectively, to prepare a mixed solution with a mass volume ratio of 15%. After stirring with a magnetic stirrer for 12 hours at room temperature, a clear and transparent SF/PLCL electrospinning solution is obtained. The SF/PLCL electrospinning solution is transferred to a 10mL medical syringe, a 20G needle is connected to the syringe, and then the syringe is placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15kV, the propulsion pump rate is set to 1.2mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the rotation speed is 1000r/min, and the receiving distance is fixed to 15cm. The whole process is carried out at room temperature and the air humidity is 15-20%. The single-layer membrane prepared in this step is named 8SF/2P.

(3)基于丝素蛋白的纳米纤维双层膜的制备方法为:在SF/nHA层形成的多孔疏松膜基础上再纺SF/PLCL层致密膜,形成丝素基三维结构双层膜。制备的双层膜分别命名为nHA@SF-8SF/2P。纺丝完毕后将电纺膜放置于真空干燥箱48小时除去膜上残留的有机溶剂,随后于EDC-NHS体系中交联4h,溶剂为无水乙醇,用去离子水将残留交联剂冲洗干净后置于冷冻干燥机中,最终干燥的丝素基三维结构双层膜。(3) The preparation method of the nanofiber double-layer membrane based on silk fibroin is as follows: on the basis of the porous loose membrane formed by the SF/nHA layer, a dense membrane of the SF/PLCL layer is spun to form a silk-based three-dimensional structure double-layer membrane. The prepared double-layer membranes are named nHA@SF-8SF/2P. After spinning, the electrospun membrane is placed in a vacuum drying oven for 48 hours to remove the residual organic solvent on the membrane, and then cross-linked in the EDC-NHS system for 4 hours, the solvent is anhydrous ethanol, and the residual cross-linking agent is rinsed with deionized water and placed in a freeze dryer to finally dry the silk-based three-dimensional structure double-layer membrane.

实施例5Example 5

本实施例提供一种丝素基三维结构双层膜及其制备方法,所述制备方法包括以下步骤:This embodiment provides a silk fibroin-based three-dimensional structure double-layer membrane and a preparation method thereof, the preparation method comprising the following steps:

(1)多孔疏松膜的制备方法为:将冷冻干燥后的丝素蛋白与纳米羟基磷灰石颗粒以质量比20:3溶解在10mL六氟异丙醇(HFIP)中,配置成质量体积比为15%的混合溶液。超声波震荡处理30min使其分散,在室温条件下用磁力搅拌器搅拌24小时后得到乳白色的SF/nHA静电纺丝液。将SF/nHA静电纺丝液分批次转移到10mL的医用注射器中,给注射器连接上型号为20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.0mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为1000r/min,接收距离固定为12cm。整个过程都在室温条件下进行,空气湿度为15-20%,制备的单层膜命名为nHA@SF。(1) The preparation method of the porous loose membrane is as follows: freeze-dried silk fibroin and nano-hydroxyapatite particles are dissolved in 10 mL of hexafluoroisopropanol (HFIP) at a mass ratio of 20:3 to prepare a mixed solution with a mass volume ratio of 15%. Ultrasonic oscillation treatment is performed for 30 minutes to disperse them, and a milky SF/nHA electrospinning solution is obtained after stirring with a magnetic stirrer for 24 hours at room temperature. The SF/nHA electrospinning solution is transferred into a 10 mL medical syringe in batches, and a 20G needle is connected to the syringe. The syringe is then placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15 kV, the propulsion pump rate is set to 1.0 mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the rotation speed is 1000 r/min, and the receiving distance is fixed to 12 cm. The entire process is carried out at room temperature, the air humidity is 15-20%, and the prepared single-layer membrane is named nHA@SF.

(2)致密膜的制备方法为:分别取丝素蛋白和聚L-丙交酯-己内酯以质量比分别为8:2比例溶解六氟异丙醇中,配置成质量体积比为15%的混合溶液。在室温条件下用磁力搅拌器搅拌12小时后得到澄清透明的SF/PLCL静电纺丝液。将SF/PLCL静电纺丝液转移到10mL的医用注射器中,给注射器连接上型号20G的针头,随后将注射器置入推进泵中,连接上高压发生器,电压设定为15kV,推进泵速率设定为1.2mL/h,并在推进泵下方放置静电纺滚筒接收纤维,转速为1000r/min,接收距离固定为15cm。整个过程都在室温条件下进行,空气湿度为15~20%。该步骤制备的单层膜命名为8SF/2P。(2) The preparation method of the dense membrane is as follows: silk fibroin and poly (L-lactide-caprolactone) are dissolved in hexafluoroisopropanol in a mass ratio of 8:2, respectively, to prepare a mixed solution with a mass volume ratio of 15%. After stirring with a magnetic stirrer for 12 hours at room temperature, a clear and transparent SF/PLCL electrospinning solution is obtained. The SF/PLCL electrospinning solution is transferred to a 10mL medical syringe, a 20G needle is connected to the syringe, and then the syringe is placed in a propulsion pump, connected to a high-voltage generator, the voltage is set to 15kV, the propulsion pump rate is set to 1.2mL/h, and an electrospinning drum is placed under the propulsion pump to receive the fiber, the rotation speed is 1000r/min, and the receiving distance is fixed to 15cm. The whole process is carried out at room temperature and the air humidity is 15-20%. The single-layer membrane prepared in this step is named 8SF/2P.

(3)基于丝素蛋白的纳米纤维双层膜的制备方法为:在SF/nHA层形成的多孔疏松膜基础上再纺SF/PLCL层致密膜,形成丝素基三维结构双层膜。制备的双层膜分别命名为nHA@SF-8SF/2P。纺丝完毕后将电纺膜放置于真空干燥箱48小时除去膜上残留的有机溶剂,随后于EDC-NHS体系中交联4h,溶剂为无水乙醇,用去离子水将残留交联剂冲洗干净后置于冷冻干燥机中,最终干燥的丝素基三维结构双层膜。(3) The preparation method of the nanofiber double-layer membrane based on silk fibroin is as follows: on the basis of the porous loose membrane formed by the SF/nHA layer, a dense membrane of the SF/PLCL layer is spun to form a silk-based three-dimensional structure double-layer membrane. The prepared double-layer membranes are named nHA@SF-8SF/2P. After spinning, the electrospun membrane is placed in a vacuum drying oven for 48 hours to remove the residual organic solvent on the membrane, and then cross-linked in the EDC-NHS system for 4 hours, the solvent is anhydrous ethanol, and the residual cross-linking agent is rinsed with deionized water and placed in a freeze dryer to finally dry the silk-based three-dimensional structure double-layer membrane.

实施例3、实施例4、实施例5制备得到的内层纳米纤维膜的扫描电镜(Hitachi,TM-1000)图分别如图6中A、B、C所示,均观察到了纤维间掺杂了nHA,实施例4中nHA含量最多,但纤维相较于实施例3较细,推测是nHA含量过多堵塞静电纺丝针头,使得纤维直径偏小;而实施例5相较于实施例3,nHA含量过低,使得nHA在纤维中分布不均。综上,实施例3中SF与nHA的比例最为合适。The scanning electron microscope (Hitachi, TM-1000) images of the inner nanofiber membranes prepared in Example 3, Example 4, and Example 5 are shown in Figure 6 A, B, and C, respectively. It is observed that nHA is doped between the fibers. The nHA content in Example 4 is the highest, but the fibers are thinner than those in Example 3. It is speculated that the excessive nHA content blocks the electrospinning needle, making the fiber diameter smaller; and the nHA content in Example 5 is too low compared to Example 3, making nHA unevenly distributed in the fibers. In summary, the ratio of SF to nHA in Example 3 is the most appropriate.

对比例1Comparative Example 1

与实施例1不同之处仅在于,所述制备方法中不包括步骤(3),即不发生交联。The only difference from Example 1 is that the preparation method does not include step (3), that is, no cross-linking occurs.

对比例2Comparative Example 2

与实施例1不同之处仅在于将步骤(1)和步骤(2)中使用的溶剂六氟异丙醇替换为三氟乙酸。The only difference from Example 1 is that the solvent hexafluoroisopropanol used in step (1) and step (2) is replaced by trifluoroacetic acid.

对比例3Comparative Example 3

与实施例1不同之处仅在于将步骤(3)中交联剂EDC-NHS体系替换为单宁酸。The only difference from Example 1 is that the cross-linking agent EDC-NHS system in step (3) is replaced by tannic acid.

对实施例2和对比例1得到的膜进行体外降解测试,测试方法为采用人工唾液(pH=6.8)模拟丝素基纳米纤维双层膜的降解过程。将交联的nHA@SF-8SF/2P和未交联的nHA@SF-8SF/2P样品裁剪成2.5cm×2.5cm大小,并在烘干称重后记录其质量为W0。随后,将样品转移至5mL的人工唾液中,放置在37℃摇床上。在3、7、14、21、28和49d时,取出样品后,使用去离子水对其进行几遍重洗并将其冻干,此时质量记为W。通过公式计算样品的剩余质量百分比(Remaining Mass):Remaining Mass(%)=(W/W0)×100%。The membranes obtained in Example 2 and Comparative Example 1 were subjected to an in vitro degradation test, and the test method was to use artificial saliva (pH = 6.8) to simulate the degradation process of the silk-based nanofiber double-layer membrane. The cross-linked nHA@SF-8SF/2P and uncross-linked nHA@SF-8SF/2P samples were cut into 2.5 cm × 2.5 cm sizes, and their masses were recorded as W 0 after drying and weighing. Subsequently, the samples were transferred to 5 mL of artificial saliva and placed on a 37°C shaker. At 3, 7, 14, 21, 28 and 49 days, after taking out the samples, they were rewashed several times with deionized water and freeze-dried, and the mass was recorded as W. The remaining mass percentage (Remaining Mass) of the sample was calculated by the formula: Remaining Mass (%) = (W/W 0 ) × 100%.

测试结果如图7所示。可以看出,交联后的nHA@SF-8SF/2P双层膜整体呈现出较为平稳的降解曲线,经过7周的降解,双层膜质量下降仍保持在75%以上。而未交联的nHA@SF-8SF/2P双层膜在第一周基本完全降解。说明交联剂的使用对材料的降解性能具有较大的作用。The test results are shown in Figure 7. It can be seen that the cross-linked nHA@SF-8SF/2P double-layer membrane presents a relatively stable degradation curve as a whole. After 7 weeks of degradation, the mass loss of the double-layer membrane remains above 75%. The uncross-linked nHA@SF-8SF/2P double-layer membrane is basically completely degraded in the first week. This shows that the use of cross-linking agents has a great effect on the degradation performance of the material.

对实施例2和对比例2得到的膜进行SEM观察,测试方法为:将静电纺溶剂为六氟异丙醇的8SF/2P与溶剂为三氟乙酸的8SF/2P样品切割成1.0cm×1.0cm大小的正方形。随后选择合适的扫描电镜样品台,用导电胶将切割好的样品固定在样品台上,在一定真空度下以直流4mA的状态对样品喷金60秒,从而使样品表面具有导电性。最后放置入扫描电镜下进行拍摄。The membranes obtained in Example 2 and Comparative Example 2 were observed by SEM. The test method was as follows: 8SF/2P samples whose electrospinning solvent was hexafluoroisopropanol and 8SF/2P samples whose solvent was trifluoroacetic acid were cut into squares of 1.0 cm×1.0 cm. Then, a suitable SEM sample stage was selected, and the cut samples were fixed on the sample stage with conductive glue. The samples were sprayed with gold for 60 seconds at a DC current of 4 mA under a certain vacuum degree, so that the sample surface had conductivity. Finally, the samples were placed under a SEM for photographing.

测试结果如图8所示,(A)溶剂为六氟异丙醇,(B)溶剂为三氟乙酸,可以看出,当静电纺丝溶剂为六氟异丙醇时能够形成较为连续,且粗细、大小一致的纤维结构,当静电纺丝溶剂为三氟乙酸时不能形成完整的纤维结构,且有液滴滴落。The test results are shown in Figure 8. (A) The solvent is hexafluoroisopropanol, and (B) The solvent is trifluoroacetic acid. It can be seen that when the electrospinning solvent is hexafluoroisopropanol, a relatively continuous fiber structure with uniform thickness and size can be formed. When the electrospinning solvent is trifluoroacetic acid, a complete fiber structure cannot be formed and droplets fall.

对实施例1和对比例3得到的膜进行观测。The films obtained in Example 1 and Comparative Example 3 were observed.

测试结果如图9所示,(A)交联剂为单宁酸,(B)交联剂为EDC-NHS,可以看出,交联剂为单宁酸的膜在动干后表面较为粗糙,且在接触后易发生破碎;交联剂为EDC-NHS表面较为光滑,且多次折叠弯曲而不易破碎。The test results are shown in Figure 9. (A) The crosslinking agent is tannic acid, and (B) the crosslinking agent is EDC-NHS. It can be seen that the surface of the membrane with tannic acid as the crosslinking agent is relatively rough after drying, and is easily broken after contact; the surface of the membrane with EDC-NHS as the crosslinking agent is relatively smooth, and is not easy to break after multiple folding and bending.

申请人声明,本发明通过上述实施例来说明本发明的用于牙周再生的丝素基三维结构双层膜及其制备方法和应用,但本发明并不局限于上述实施例,即不意味着本发明必须依赖上述实施例才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明所选用原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。The applicant declares that the present invention uses the above-mentioned embodiments to illustrate the silk-based three-dimensional structured double-layer membrane for periodontal regeneration and its preparation method and application, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of the raw materials selected by the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

Claims (26)

1.一种用于牙周再生的丝素基三维结构双层膜,其特征在于,其包括内层的多孔疏松层和外层的致密层,所述多孔疏松层是丝素蛋白和纳米羟基磷灰石组成的纳米纤维膜,所述致密层是丝素蛋白与生物可降解材料组成的纳米纤维膜,所述多孔疏松层和致密层之间形成交联结构;1. A silk-based three-dimensional double-layer membrane for periodontal regeneration, characterized in that it comprises an inner porous loose layer and an outer dense layer, wherein the porous loose layer is a nanofiber membrane composed of silk fibroin and nano-hydroxyapatite, and the dense layer is a nanofiber membrane composed of silk fibroin and biodegradable materials, and a cross-linked structure is formed between the porous loose layer and the dense layer; 所述用于牙周再生的丝素基三维结构双层膜采用如下方法进行制备,所述方法包括以下步骤:The silk-based three-dimensional structured double-layer membrane for periodontal regeneration is prepared by the following method, which comprises the following steps: (1)以含有丝素蛋白与纳米羟基磷灰石的溶液为静电纺丝液,通过静电纺丝得到多孔疏松层;(1) Using a solution containing silk fibroin and nano-hydroxyapatite as an electrospinning solution, a porous loose layer is obtained by electrospinning; (2)以含有丝素蛋白与生物可降解材料的溶液为静电纺丝液,通过静电纺丝,在得到的多孔疏松层上接收并得到致密层;(2) using a solution containing silk fibroin and biodegradable materials as an electrospinning solution, and receiving and obtaining a dense layer on the obtained porous loose layer through electrospinning; (3)使用交联剂使得多孔疏松层和致密层发生交联,得到所述用于牙周再生的丝素基三维结构双层膜。(3) Using a cross-linking agent to cross-link the porous loose layer and the dense layer to obtain the silk-based three-dimensional structured double-layer membrane for periodontal regeneration. 2.根据权利要求1所述的用于牙周再生的丝素基三维结构双层膜,其特征在于,所述多孔疏松层中纳米羟基磷灰石的质量比为10%~30%。2. The silk-based three-dimensional structured double-layer membrane for periodontal regeneration according to claim 1, characterized in that the mass ratio of nano-hydroxyapatite in the porous loose layer is 10% to 30%. 3.根据权利要求1所述的用于牙周再生的丝素基三维结构双层膜,其特征在于,所述纳米羟基磷灰石的粒径为20~40 nm。3 . The silk-based three-dimensional structured double-layer membrane for periodontal regeneration according to claim 1 , wherein the particle size of the nano-hydroxyapatite is 20 to 40 nm. 4.根据权利要求1所述的用于牙周再生的丝素基三维结构双层膜,其特征在于,所述致密层中丝素蛋白的重量百分比为50%~100%。4. The silk-based three-dimensional structured double-layer membrane for periodontal regeneration according to claim 1, characterized in that the weight percentage of silk fibroin in the dense layer is 50% to 100%. 5.根据权利要求1所述的用于牙周再生的丝素基三维结构双层膜,其特征在于,所述生物可降解材料选自聚乳酸、聚己内酯或聚羟基丁酸戊酸共聚酯中的任意一种或至少两种的组合。5. The silk-based three-dimensional structure double-layer membrane for periodontal regeneration according to claim 1, characterized in that the biodegradable material is selected from any one of polylactic acid, polycaprolactone or polyhydroxybutyrate-valeric acid copolyester or a combination of at least two thereof. 6.根据权利要求1所述的用于牙周再生的丝素基三维结构双层膜,其特征在于,所述交联使用的交联剂为碳化二亚胺盐和羟基丁二酰亚胺。6 . The silk-based three-dimensional structured double-layer membrane for periodontal regeneration according to claim 1 , wherein the cross-linking agent used for the cross-linking is carbodiimide salt and hydroxysuccinimide. 7.根据权利要求6所述的用于牙周再生的丝素基三维结构双层膜,其特征在于,所述碳化二亚胺盐和羟基丁二酰亚胺的质量比为20%~30%。7 . The silk-based three-dimensional structured double-layer membrane for periodontal regeneration according to claim 6 , wherein the mass ratio of the carbodiimide salt to hydroxysuccinimide is 20% to 30%. 8.根据权利要求1-7中任一项所述的用于牙周再生的丝素基三维结构双层膜的制备方法,其特征在于,所述制备方法包括以下步骤:8. The method for preparing a silk fibroin-based three-dimensional structured double-layer membrane for periodontal regeneration according to any one of claims 1 to 7, characterized in that the preparation method comprises the following steps: (1)以含有丝素蛋白与纳米羟基磷灰石的溶液为静电纺丝液,通过静电纺丝得到多孔疏松层;(1) Using a solution containing silk fibroin and nano-hydroxyapatite as an electrospinning solution, a porous loose layer is obtained by electrospinning; (2)以含有丝素蛋白与生物可降解材料的溶液为静电纺丝液,通过静电纺丝,在得到的多孔疏松层上接收并得到致密层;(2) using a solution containing silk fibroin and biodegradable materials as an electrospinning solution, and receiving and obtaining a dense layer on the obtained porous loose layer through electrospinning; (3)使用交联剂使得多孔疏松层和致密层发生交联,得到所述用于牙周再生的丝素基三维结构双层膜。(3) Using a cross-linking agent to cross-link the porous loose layer and the dense layer to obtain the silk-based three-dimensional structured double-layer membrane for periodontal regeneration. 9.根据权利要求8所述的制备方法,其特征在于,步骤(1)所述含有丝素蛋白与纳米羟基磷灰石的溶液中丝素蛋白与纳米羟基磷灰石的总质量百分比为15%~25%。9. The preparation method according to claim 8, characterized in that the total mass percentage of silk fibroin and nano-hydroxyapatite in the solution containing silk fibroin and nano-hydroxyapatite in step (1) is 15% to 25%. 10.根据权利要求8所述的制备方法,其特征在于,步骤(1)所述含有丝素蛋白与纳米羟基磷灰石的溶液的溶剂为六氟异丙醇。10 . The preparation method according to claim 8 , characterized in that the solvent of the solution containing silk fibroin and nano-hydroxyapatite in step (1) is hexafluoroisopropanol. 11.根据权利要求8所述的制备方法,其特征在于,步骤(1)所述含有丝素蛋白与纳米羟基磷灰石的溶液的配制过程为:将冷冻干燥后的丝素蛋白与纳米羟基磷灰石颗粒加入至六氟异丙醇中,得到混合溶液,将混合溶液利用超声波震荡处理,而后搅拌,得到所述含有丝素蛋白与纳米羟基磷灰石的溶液。11. The preparation method according to claim 8, characterized in that the preparation process of the solution containing silk fibroin and nano-hydroxyapatite in step (1) is: adding freeze-dried silk fibroin and nano-hydroxyapatite particles to hexafluoroisopropanol to obtain a mixed solution, treating the mixed solution with ultrasonic vibration, and then stirring to obtain the solution containing silk fibroin and nano-hydroxyapatite. 12.根据权利要求11所述的制备方法,其特征在于,所述超声波震荡处理时的超声频率为19-23KHz,处理时间为10-40min。12. The preparation method according to claim 11, characterized in that the ultrasonic frequency during the ultrasonic oscillation treatment is 19-23 KHz, and the treatment time is 10-40 min. 13.根据权利要求11所述的制备方法,其特征在于,所述搅拌的时间为3-48小时。13. The preparation method according to claim 11, characterized in that the stirring time is 3-48 hours. 14.根据权利要求8所述的制备方法,其特征在于,步骤(1)所述静电纺丝时电压设定为10~20 kV,进样速率设定为0.8~1.5 mL/h,利用滚筒接收纤维,滚筒转速为800~3000 r/min,接收距离为10~15 cm;14. The preparation method according to claim 8, characterized in that, during the electrospinning in step (1), the voltage is set to 10-20 kV, the sample feed rate is set to 0.8-1.5 mL/h, the fiber is received by a roller, the roller speed is 800-3000 r/min, and the receiving distance is 10-15 cm; 步骤(1)所述静电纺丝在室温下进行,空气湿度为15-20%。The electrospinning in step (1) is carried out at room temperature with an air humidity of 15-20%. 15.根据权利要求8所述的制备方法,其特征在于,步骤(2)含有丝素蛋白与生物可降解材料的溶液中丝素蛋白与生物可降解材料的质量百分比为10%~20%。15. The preparation method according to claim 8, characterized in that the mass percentage of silk fibroin and biodegradable material in the solution containing silk fibroin and biodegradable material in step (2) is 10% to 20%. 16.根据权利要求8所述的制备方法,其特征在于,步骤(2)含有丝素蛋白与生物可降解材料的溶液的溶剂为六氟异丙醇、三氟乙酸、乙酸或四氢呋喃中的至少一种。16. The preparation method according to claim 8, characterized in that the solvent of the solution containing silk fibroin and biodegradable material in step (2) is at least one of hexafluoroisopropanol, trifluoroacetic acid, acetic acid or tetrahydrofuran. 17.根据权利要求8所述的制备方法,其特征在于,步骤(2)所述含有丝素蛋白与生物可降解材料的溶液的配制过程为:将丝素蛋白与生物可降解材料加入至六氟异丙醇中得到混合溶液,搅拌,得到所述含有丝素蛋白与生物可降解材料的溶液。17. The preparation method according to claim 8, characterized in that the preparation process of the solution containing silk fibroin and biodegradable material in step (2) is: adding silk fibroin and biodegradable material to hexafluoroisopropanol to obtain a mixed solution, stirring, and obtaining the solution containing silk fibroin and biodegradable material. 18.根据权利要求17所述的制备方法,其特征在于,所述搅拌的时间为3-24小时。18. The preparation method according to claim 17, characterized in that the stirring time is 3-24 hours. 19.根据权利要求8所述的制备方法,其特征在于,步骤(2)所述静电纺丝时电压设定为10~20kV,进样速率设定为0.8~1.5 mL/h,利用滚筒接收纤维,滚筒转速为800~3000 r/min,接收距离为10~15 cm。19. The preparation method according to claim 8, characterized in that, during the electrospinning in step (2), the voltage is set to 10-20 kV, the sample feed rate is set to 0.8-1.5 mL/h, the fiber is received by a roller, the roller speed is 800-3000 r/min, and the receiving distance is 10-15 cm. 20.根据权利要求8所述的制备方法,其特征在于,步骤(2)所述静电纺丝在室温下进行,空气湿度为15-20%。20. The preparation method according to claim 8, characterized in that the electrospinning in step (2) is carried out at room temperature with an air humidity of 15-20%. 21.根据权利要求8所述的制备方法,其特征在于,步骤(3)所述交联剂为碳化二亚胺盐和羟基丁二酰亚胺。21. The preparation method according to claim 8, characterized in that the cross-linking agent in step (3) is carbodiimide salt and hydroxysuccinimide. 22.根据权利要求21所述的制备方法,其特征在于,所述碳化二亚胺盐和羟基丁二酰亚胺的质量比为20%~30%。22. The preparation method according to claim 21, characterized in that the mass ratio of the carbodiimide salt to hydroxysuccinimide is 20% to 30%. 23.根据权利要求8所述的制备方法,其特征在于,步骤(3)所述交联在室温下进行,所述交联的时间为1-6小时。23. The preparation method according to claim 8, characterized in that the cross-linking in step (3) is carried out at room temperature and the cross-linking time is 1-6 hours. 24.根据权利要求8所述的制备方法,其特征在于,步骤(3)所述交联在有机溶剂中进行,所述有机溶剂为无水乙醇。24. The preparation method according to claim 8, characterized in that the cross-linking in step (3) is carried out in an organic solvent, and the organic solvent is anhydrous ethanol. 25.根据权利要求8所述的制备方法,其特征在于,步骤(3)在交联前,将步骤(2)得到的双层膜进行干燥,除去膜上残留的有机溶剂。25. The preparation method according to claim 8, characterized in that, in step (3), the double-layer membrane obtained in step (2) is dried before cross-linking to remove the organic solvent remaining on the membrane. 26.根据权利要求1-7中任一项所述的用于牙周再生的丝素基三维结构双层膜在口腔种植材料制备中的应用。26. Use of the silk-based three-dimensional structured double-layer membrane for periodontal regeneration according to any one of claims 1 to 7 in the preparation of oral implant materials.
CN202310557229.4A 2023-05-17 2023-05-17 Silk fibroin-based three-dimensional structure bilayer membrane for periodontal regeneration and preparation method and application thereof Active CN116392647B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310557229.4A CN116392647B (en) 2023-05-17 2023-05-17 Silk fibroin-based three-dimensional structure bilayer membrane for periodontal regeneration and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310557229.4A CN116392647B (en) 2023-05-17 2023-05-17 Silk fibroin-based three-dimensional structure bilayer membrane for periodontal regeneration and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN116392647A CN116392647A (en) 2023-07-07
CN116392647B true CN116392647B (en) 2024-04-09

Family

ID=87014394

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310557229.4A Active CN116392647B (en) 2023-05-17 2023-05-17 Silk fibroin-based three-dimensional structure bilayer membrane for periodontal regeneration and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN116392647B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524643A (en) * 2014-11-26 2015-04-22 北京化工大学 Halloysite-nanotube-containing drug-loaded type guide tissue regeneration membrane and preparation method thereof
CN109908392A (en) * 2019-03-27 2019-06-21 广州创赛生物医用材料有限公司 Novel asymmetric wettability electrostatic spinning duplicature of one kind and preparation method thereof
CN111298198A (en) * 2019-04-18 2020-06-19 上海交通大学医学院附属第九人民医院 A double-layer absorbable bionic barrier film and its preparation method and application
CN113018519A (en) * 2021-03-15 2021-06-25 武汉亚洲生物材料有限公司 Mineralization guide tissue regeneration membrane and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842780B2 (en) * 2003-01-07 2010-11-30 Trustees Of Tufts College Silk fibroin materials and use thereof
KR100762928B1 (en) * 2004-10-29 2007-10-04 재단법인서울대학교산학협력재단 Non-woven form of bone tissue-induced regeneration shielding membrane made of silk fibroin nanofibers and method for manufacturing same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524643A (en) * 2014-11-26 2015-04-22 北京化工大学 Halloysite-nanotube-containing drug-loaded type guide tissue regeneration membrane and preparation method thereof
CN109908392A (en) * 2019-03-27 2019-06-21 广州创赛生物医用材料有限公司 Novel asymmetric wettability electrostatic spinning duplicature of one kind and preparation method thereof
CN111298198A (en) * 2019-04-18 2020-06-19 上海交通大学医学院附属第九人民医院 A double-layer absorbable bionic barrier film and its preparation method and application
CN113018519A (en) * 2021-03-15 2021-06-25 武汉亚洲生物材料有限公司 Mineralization guide tissue regeneration membrane and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Preparation of SF/SF-nHA double-layer scaffolds for periodental tissue regeneration;Ying Guo等;International Journal of Polymeric Materials and Polymeric Biomaterials;第72卷(第18期);1445-1454 *
后处理对静电纺丝素蛋白结构和性能的影响;窦皓等;丝绸;49(第09期);23-29 *

Also Published As

Publication number Publication date
CN116392647A (en) 2023-07-07

Similar Documents

Publication Publication Date Title
KR100762928B1 (en) Non-woven form of bone tissue-induced regeneration shielding membrane made of silk fibroin nanofibers and method for manufacturing same
CN112553785B (en) Double-layer guided tissue regeneration membrane and preparation method thereof
CN103948974B (en) Carry Types of Medicine guide tissue regeneration film and preparation method thereof
CN103341209B (en) Silk fibroin nanofiber membrane and preparation method thereof
WO2019192116A1 (en) Charged composite membrane having electrical topology characteristics of extracellular matrix and preparation method therefor
CN103736153A (en) Single-layer and double-layer polycaprolactone-based guided tissue regeneration membranes and preparation method thereof
CN104524643A (en) Halloysite-nanotube-containing drug-loaded type guide tissue regeneration membrane and preparation method thereof
CN111962210B (en) Polycaprolactone/methacryloylated elastin nanofiber composite membrane and preparation method and application thereof
CN106860915B (en) A kind of mineralized collagen biomimetic bone repair material modified by hyaluronic acid oligosaccharide and its preparation method
CN106400311A (en) Method for preparing composite nanofiber tissue engineering scaffold based on graphene oxide
CN113332497B (en) A double-sided stent and its preparation method and application
CN107693845A (en) The bilayer that ectonexine loads HAp and VEGF respectively imitates periosteum material
CN113975469A (en) Electrostatic spinning sandwich-like silk fibroin composite nanofiber membrane and preparation method thereof
CN106421903A (en) Blue shark fishskin collagen periodontium guided regeneration nanofiber membrane and preparing method thereof
CN111617303A (en) A kind of preparation method of high-strength nanofiber membrane wound dressing
CN111793899A (en) Biomimetic nanofiber material and its preparation method and application
CN110229247A (en) Based on alginic acid derivative electrospun nanofiber composite cellulosic membrane medical dressing and preparation method thereof
CN119015516B (en) Double-layer oral cavity repairing film material and preparation method thereof
CN116392647B (en) Silk fibroin-based three-dimensional structure bilayer membrane for periodontal regeneration and preparation method and application thereof
CN110201240A (en) Modified cell epimatrix hydrogel and its preparation method and application, tissue engineering material
CN103741262B (en) A kind of chitosan nano fibrous membrane for cerebral dura mater or Broken dura remedy and preparation method thereof and application
CN112295021A (en) A skin graft with improved topology
CN114146227B (en) Preparation method of flexible directional nanofiber composite membrane capable of promoting vascular regeneration
CN111996676A (en) Composite nanofiber, absorbable membrane and preparation method and application of absorbable membrane
CN114848504B (en) DNA-hydroxyapatite composite material for manufacturing antibacterial tooth inlays and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20230707

Assignee: SHANGHAI SHUANGSHEN MEDICAL INSTRUMENT CO.,LTD.

Assignor: Shanghai Liyuan Medical Technology Co.,Ltd.

Contract record no.: X2025980009361

Denomination of invention: A silk based three-dimensional double-layer membrane for periodontal regeneration, its preparation method and application

Granted publication date: 20240409

License type: Common License

Record date: 20250526